Neuberger Berman Group
SRPT icon

Neuberger Berman Group’s Sarepta Therapeutics SRPT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,530
Closed -$353K 2109
2025
Q1
$353K Buy
5,530
+1,211
+28% +$77.3K ﹤0.01% 1642
2024
Q4
$525K Sell
4,319
-116,387
-96% -$14.2M ﹤0.01% 1509
2024
Q3
$15.1M Buy
120,706
+32,255
+36% +$4.03M 0.01% 717
2024
Q2
$14M Buy
88,451
+2,790
+3% +$441K 0.01% 717
2024
Q1
$11.1M Buy
85,661
+15,520
+22% +$2.01M 0.01% 765
2023
Q4
$6.76M Sell
70,141
-1,080
-2% -$104K 0.01% 839
2023
Q3
$8.63M Sell
71,221
-28
-0% -$3.39K 0.01% 767
2023
Q2
$8.16M Buy
71,249
+22
+0% +$2.52K 0.01% 782
2023
Q1
$9.82M Buy
71,227
+66,988
+1,580% +$9.23M 0.01% 751
2022
Q4
$549K Sell
4,239
-11
-0.3% -$1.43K ﹤0.01% 1418
2022
Q3
$470K Buy
4,250
+105
+3% +$11.6K ﹤0.01% 1489
2022
Q2
$311K Buy
4,145
+1,305
+46% +$97.9K ﹤0.01% 1626
2022
Q1
$222K Buy
+2,840
New +$222K ﹤0.01% 1778
2021
Q1
Sell
-37,779
Closed -$6.42M 1801
2020
Q4
$6.42M Buy
+37,779
New +$6.42M 0.01% 859
2019
Q3
Sell
-61,500
Closed -$9.35M 1586
2019
Q2
$9.35M Buy
61,500
+1,500
+3% +$228K 0.01% 769
2019
Q1
$7.15M Sell
60,000
-2,053
-3% -$245K 0.01% 792
2018
Q4
$6.77M Sell
62,053
-69,500
-53% -$7.58M 0.01% 791
2018
Q3
$21.2M Sell
131,553
-667
-0.5% -$108K 0.02% 630
2018
Q2
$17.5M Buy
132,220
+107,042
+425% +$14.1M 0.02% 667
2018
Q1
$1.87M Buy
25,178
+7,403
+42% +$548K ﹤0.01% 1036
2017
Q4
$989K Sell
17,775
-7,225
-29% -$402K ﹤0.01% 1212
2017
Q3
$1.13M Buy
+25,000
New +$1.13M ﹤0.01% 1120